PMID | Title | Journal | Publication Year | Author | View in RVdb |
---|---|---|---|---|---|
16611122 | Current status of anti-picornavirus therapies. | Curr Pharm Des | 2006 | Barnard DL | View More |
2559655 | In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug. | Antimicrob Agents Chemother | 1989 | Woods MG;Diana GD;Rogge MC;Otto MJ;Dutko FJ;McKinlay MA | View More |
29024767 | Modulation of proteolytic polyprotein processing by coxsackievirus mutants resistant to inhibitors targeting phosphatidylinositol-4-kinase IIIbeta or oxysterol binding protein. | Antiviral Res | 2017 | Lyoo H;Dorobantu CM;van der Schaar HM;van Kuppeveld FJM | View More |
3005578 | Antipicornavirus activity of substituted phenoxybenzenes and phenoxypyridines. | J Med Chem | 1986 | Markley LD;Tong YC;Dulworth JK;Steward DL;Goralski CT;Johnston H;Wood SG;Vinogradoff AP;Bargar TM | View More |
32231022 | Antiviral Effects of Menthol on Coxsackievirus B. | Viruses | 2020 | Taylor DJR;Hamid SM;Andres AM;Saadaeijahromi H;Piplani H;Germano JF;Song Y;Sawaged S;Feuer R;Pandol SJ;Sin J | View More |
37156267 | Anisomycin inhibits Coxsackievirus B replication by promoting the lysosomal degradation of eEF1A1. | Antiviral Res | 2023 | Shao E;Zhao S;Dong Y;Wang Y;Fei Y;Li S;Wang L;Bashir T;Luan T;Lin L;Wang Y;Zhao W;Zhong Z | View More |